ArticleInvestigative ophthalmology & visual science2026
Longitudinal In Vitro Assessment of the Optical Transparency of Preserved Pre-Descemet Layer in the Absence of Corneal Endothelium.
Article in Investigative ophthalmology & visual science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: The purpose of this study was to evaluate the optical transparency morphological and ultrastructural features of the isolated pre-Descemet layer (PDL) in the absence of endothelium after preservation for up to 12 months using standard organ culture and silica gel-based tissue dehydration. Methods: Following removal of the Descemet membrane endothelium complex, the PDL was isolated using the big bubble technique. Ten samples were preserved either in standard organ culture medium (group 1) or by silica gel-based dehydration (group 2). Five samples with the PDL with thin posterior stroma served as the controls (group 3). Transparency was quantified using a custom-built optical device, and thickness was measured by anterior segment optical coherence tomography at baseline, 7 days, and 1, 3, 6, and 12 months. Ultrastructural analysis was then performed by transmission electron microscopy. Results: In group 1, mean transparency was 25.22 ± 4.32 lux (95% confidence interval [CI] = 19.87-30.57, SE = 1.93) at baseline and 19.13 ± 9.01 lux (95% CI = 7.94-30.32, SE = 4.03) at 12 months, with similar thickness (44.60 ± 8.42 µm (95% CI = 34.15-55.05, SE = 3.76) to 43.31 ± 8.69 µm (95% CI = 32.53-54.10, SE = 3.88). Group 2 showed comparable findings, with transparency of 20.9 ± 6.56 lux (95% CI = 12.75-29.04, SE = 2.93) at baseline and 19.37 ± 5.72 lux (95% CI = 12.26-26.47, SE = 1.56) after rehydration at 12 months, and thickness from 40.26 ± 7.73 µm (95% CI = 30.65-49.86, SE = 3.46) to 41.01 ± 8.18 µm (95% CI = 41.01-51.17, SE = 3.66). Control corneas (group 3) showed progressive loss of transparency (34.87 ± 6.56 lux, 95% CI = 26.72-43.01, SE = 2.93 to 43.4 ± 2.6 lux, 95% CI = 40.17-46.63, SE = 1.16) and stromal thickening (126.33 ± 33.25 µm (95% CI = 85.04-167.43, SE = 14.87) to 236.74 ± 61.98 µm (95% CI = 159.78-313.70, SE = 27.72). Electron microscopy revealed tightly packed collagen lamellae in groups 1 and 2 with similar appearance between preservation methods. Keratocytes were observed in group 3. Conclusions: Preserved PDL retains in vitro its transparency and thickness independent of endothelial function over 1 year.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.